225 related articles for article (PubMed ID: 9065515)
21. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
Florin SM; Kuczenski R; Segal DS
J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
[TBL] [Abstract][Full Text] [Related]
22. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
23. Regional norepinephrine response to amphetamine using dialysis: comparison with caudate dopamine.
Kuczenski R; Segal DS
Synapse; 1992 Jun; 11(2):164-9. PubMed ID: 1626314
[TBL] [Abstract][Full Text] [Related]
24. Sensitization of amphetamine-induced stereotyped behaviors during the acute response.
Kuczenski R; Segal DS
J Pharmacol Exp Ther; 1999 Feb; 288(2):699-709. PubMed ID: 9918578
[TBL] [Abstract][Full Text] [Related]
25. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
Kuczenski R; Segal DS; Aizenstein ML
J Neurosci; 1991 Sep; 11(9):2703-12. PubMed ID: 1715389
[TBL] [Abstract][Full Text] [Related]
26. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
[TBL] [Abstract][Full Text] [Related]
27. The use of d-amphetamine pellet implantation as a model for d-amphetamine tolerance in the mouse.
Hitzemann RJ; Loh HH; Craves FB; Domino EF
Psychopharmacologia; 1973 Jun; 30(3):227-40. PubMed ID: 4736782
[No Abstract] [Full Text] [Related]
28. Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment.
Amato D; Natesan S; Yavich L; Kapur S; Müller CP
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1327-39. PubMed ID: 21281560
[TBL] [Abstract][Full Text] [Related]
29. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
[No Abstract] [Full Text] [Related]
30. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.
Robinson TE; Jurson PA; Bennett JA; Bentgen KM
Brain Res; 1988 Oct; 462(2):211-22. PubMed ID: 2847849
[TBL] [Abstract][Full Text] [Related]
31. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Psychopharmacology (Berl); 2005 Jul; 180(3):501-12. PubMed ID: 15959831
[TBL] [Abstract][Full Text] [Related]
32. Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis.
Nielsen EB; Lyon M; Ellison G
J Nerv Ment Dis; 1983 Apr; 171(4):222-33. PubMed ID: 6834023
[TBL] [Abstract][Full Text] [Related]
33. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
Jones GH; Hernandez TD; Kendall DA; Marsden CA; Robbins TW
Pharmacol Biochem Behav; 1992 Sep; 43(1):17-35. PubMed ID: 1384071
[TBL] [Abstract][Full Text] [Related]
34. In vivo measures of monoamines during amphetamine-induced behaviors in rats.
Kuczenski R; Segal DS
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S37-50. PubMed ID: 2097672
[TBL] [Abstract][Full Text] [Related]
35. Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices.
Lillrank SM; Oja SS; Saransaari P; Seppälä T
Int J Neurosci; 1991 Sep; 60(1-2):1-15. PubMed ID: 1685488
[TBL] [Abstract][Full Text] [Related]
36. Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine.
Schad CA; Justice JB; Holtzman SG
Eur J Pharmacol; 1995 Feb; 275(1):9-16. PubMed ID: 7774666
[TBL] [Abstract][Full Text] [Related]
37. The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.
Stocco MR; El-Sherbeni AA; Zhao B; Novalen M; Tyndale RF
Psychopharmacology (Berl); 2021 Jul; 238(7):1791-1804. PubMed ID: 33649968
[TBL] [Abstract][Full Text] [Related]
38. Hippocampal modulation of nucleus accumbens: behavioral evidence from amphetamine-induced activity profiles.
Whishaw IQ; Mittleman G
Behav Neural Biol; 1991 May; 55(3):289-306. PubMed ID: 1905533
[TBL] [Abstract][Full Text] [Related]
39. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment.
Florin SM; Kuczenski R; Segal DS
Brain Res; 1994 Aug; 654(1):53-62. PubMed ID: 7982098
[TBL] [Abstract][Full Text] [Related]
40. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
